For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
As of close of business last night, Lyra Therapeutics Inc’s stock clocked out at $22.82, down -17.26% from its previous closing price of $27.58. In other words, the price has decreased by -$17.26 from its previous closing price. On the day, 0.68 million shares were traded.
Ratios:
To gain a deeper understanding of LYRA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.96 and its Current Ratio is at 2.96. In the meantime, Its Debt-to-Equity ratio is 8.62 whereas as Long-Term Debt/Eq ratio is at 7.52.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Jefferies on May 07, 2024, Downgraded its rating to Hold and sets its target price to $0.50 from $10 previously.
On May 07, 2024, H.C. Wainwright Downgraded its rating to Neutral which previously was Buy and also lowered its target price recommendation from $12 to $2.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Apr 25 ’25 when Waksal Harlan bought 145,370 shares for $0.10 per share.
Palasis Maria bought 39,567 shares of LYRA for $3,545 on Apr 09 ’25.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 25.41 while its Price-to-Book (P/B) ratio in mrq is 7.77.
Stock Price History:
Over the past 52 weeks, LYRA has reached a high of $37.50, while it has fallen to a 52-week low of $3.81. The 50-Day Moving Average of the stock is 256.76%, while the 200-Day Moving Average is calculated to be 128.45%.
Shares Statistics:
A total of 1.32M shares are outstanding, with a floating share count of 1.12M. Insiders hold about 15.85% of the company’s shares, while institutions hold 36.57% stake in the company.
